FATE - Fate Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$4.00
DETAILS
HIGH:
$4.00
LOW:
$4.00
MEDIAN:
$4.00
CONSENSUS:
$4.00
UPSIDE:
77.78%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | -94.1% |
| EBIT Margin | -2051.1% |
| EBITDA Margin | -1911.2% |
| Operating Margin | -2222.4% |
| Pretax Margin | -2051.1% |
| Cont. Ops Margin | -2051.1% |
| Net Margin | -2051.1% |
| Bottom Line Margin | -2051.1% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 5.79 |
| Quick Ratio | 5.79 |
| Solvency Ratio | -1.137 |
| Cash Ratio | 1.29 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-0.86
Peers avg: 20.8
|
| PEG Ratio | 0.03 |
| Forward PEG | 0.03 |
| Price/Book | 0.56 |
| Price/Sales | 17.56 |
| Price/FCF | -1.04 |
| Price/Op Cash Flow | -1.10 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.2441 |
| Debt/Equity | 0.3757 |
| Debt/Capital | 0.2731 |
| Long-Term Debt/Capital | 0.2613 |
| Financial Leverage | 1.54 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.03 |
| Operating Cash Flow Ratio | -2.941 |
| Operating Cash Flow/Sales | -1596.2% |
| Free Cash Flow/Operating Cash Flow | 105.6% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -27.84 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -23.25 |
| Operating Cash Flow Coverage | -1.36 |
| Capital Expenditure Coverage | -17.82 |
| Dividend + Capital Expenditure Coverage | -17.82 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.06 |
| EPS | -1.148 |
| Debt/Share | 0.6553 |
| Cash/Share | 1.71 |
| Book Value/Share | 1.74 |
| Tangible BV/Share | 1.74 |
| Equity/Share | 1.74 |
| Operating Cash Flow/Share | -0.893 |
| Capital Expenditure/Share | 0.050 |
| FCF/Share | -0.943 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.923 |
| Price/Fair Value | 0.56 |
| Debt/Market Cap | 0.6670 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -1.16 |